Fujian Cosunter Pharmaceutical Co., Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 171.55 million compared to CNY 186.02 million a year ago. Revenue was CNY 177.49 million compared to CNY 192.5 million a year ago.

Net loss was CNY 157.22 million compared to CNY 26.22 million a year ago. Basic loss per share from continuing operations was CNY 0.9871 compared to CNY 0.1649 a year ago. Diluted loss per share from continuing operations was CNY 0.9871 compared to CNY 0.1649 a year ago.